Spyre Therapeutics, Inc. (SYRE): 8-K filed Oct 7, 2026

Form type

8-K

Filing date

Oct 7, 2026

Accession number

0001628280-26-065291

Filer

Spyre Therapeutics, Inc. (CIK 1636282)